Mark R Nehler Selected Research

Therapeutics

1/2023	Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study.
12/2022	Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
1/2022	Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
11/2021	Contemporary outcomes of traumatic popliteal artery injury repair from the popliteal scoring assessment for vascular extremity injury in trauma study.
10/2021	Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
1/2018	Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
5/2008	Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design.
5/2007	Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes.
5/2003	Functional outcomes and quality of life in peripheral arterial disease: current status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark R Nehler Research Topics

Disease

18	Peripheral Arterial Disease 05/2024 - 05/2003
10	Ischemia 01/2024 - 01/2018
8	Hemorrhage 01/2023 - 01/2020
8	Myocardial Infarction 12/2022 - 01/2018
8	Chronic Limb-Threatening Ischemia 01/2020 - 03/2003
7	Ischemic Stroke 12/2021 - 01/2018
4	Thrombosis (Thrombus) 01/2023 - 07/2015
3	Infections 01/2022 - 08/2002
3	Diabetes Mellitus 01/2022 - 05/2008
3	Wounds and Injuries (Trauma) 11/2021 - 07/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 10/2021
2	Aneurysm (Aneurysms) 02/2023 - 10/2017
2	COVID-19 01/2023 - 01/2023
2	Vascular System Injuries 11/2021 - 01/2021
2	Pain (Aches) 07/2015 - 05/2007
1	Inflammation (Inflammations) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Stroke (Strokes) 12/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Obesity 01/2022
1	Venous Thromboembolism 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021
1	Acute Coronary Syndrome 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Intermittent Claudication 07/2015
1	Arteriovenous Fistula 09/2011
1	Chronic Renal Insufficiency 09/2011
1	Kidney Diseases (Kidney Disease) 09/2011
1	Fistula 09/2011
1	Lymphocele 11/2008
1	Compartment Syndromes 11/2008
1	Pathologic Constriction (Stenosis) 05/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2008
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2008
1	Diabetic Neuropathies (Diabetic Neuropathy) 07/2003
1	Brain Hypoxia (Cerebral Hypoxia) 08/2002
1	Renal Insufficiency (Renal Failure) 08/2002
1	Wound Infection (Wound Infections) 08/2002
1	False Aneurysm (Pseudoaneurysm) 08/2002

Drug/Important Bio-Agent (IBA)

13	RivaroxabanIBA 05/2024 - 01/2018
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 01/2020
2	Clopidogrel (Plavix)FDA Link 12/2022 - 12/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 07/2015
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	Thromboplastin (Tissue Factor)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	Streptokinase FDA Link 12/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2022
1	AnticoagulantsIBA 01/2022
1	dicarboxydine (DCD)IBA 11/2021
1	TicagrelorIBA 01/2020
1	NitrogenIBA 10/2017
1	Urea (Carbamide)FDA LinkGeneric 10/2017
1	EcraprostIBA 05/2007
1	Alprostadil (Muse)FDA LinkGeneric 05/2007

Therapy/Procedure

18	Surgical Amputation (Amputations) 12/2022 - 08/2002
9	Therapeutics 01/2023 - 05/2003
2	Renal Dialysis (Hemodialysis) 01/2023 - 09/2011
2	Catheters 09/2011 - 12/2009
1	Prostheses and Implants (Prosthesis) 02/2023
1	Ambulatory Care (Outpatient Care) 01/2023
1	Operative Time 10/2017
1	Fasciotomy 11/2008
1	Ligation 11/2008
1	Limb Salvage 03/2003